Drug Type Small molecule drug |
Synonyms CT 50352, CT-50352 |
Target |
Action antagonists |
Mechanism GP IIb/IIIa antagonists(Integrin alpha-IIb/beta-3 antagonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPhase 2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Angina Pectoris | Phase 2 | United States | - | |
Myocardial Infarction | Phase 2 | United States | - | |
Stroke | Phase 2 | United States | - |